Table TDI-13. Characteristics of all men treated for drug problems in 2002 or most recent year available. Part (i) Demographics and injecting status
| Country | Year | Mean age | % Age <25 | % Age 35+ | Currently injecting any drug | |||
| Belgium | (1) | 1999 | 25.5 | 54 | 13 | 7.8 | ||
| Czech Republic | (2) | 2002 | 24.1 | 62.5 | 8.1 | 62.9 | ||
| Denmark | 2002 | 31.4 | 27 | 34 | na | |||
| Germany | (4) | 2002 | 26.7 | 51 | 17 | na | ||
| Greece | 2002 | 28.9 | 39.5 | 24.1 | 54.3 | |||
| Spain | (17) | 2002 | 31.4 | 22 | 32 | na | ||
| France | (5) | 1999 | 30.7 | 19 | 27 | 14.8 | ||
| Ireland | (6) | 2000 | 25.3 | 54.1 | 10.5 | 30.1 | ||
| Italy | (7) | 2002 | 32.4 | 15.9 | 37.2 | na | ||
| Latvia | (8) | 2002 | 26.7 | 51.7 | 16.3 | na | ||
| Lithuania | 2002 | 32.4 | 41 | 22.8 | na | |||
| Luxembourg | 2002 | 31.4 | 17 | 36 | 55 | |||
| Hungary | 2002 | 28.3 | 42 | 19 | na | |||
| Netherlands | (12) | 2002 | 33.1 | 20 | 41 | na | ||
| Austria | (13) | 2002 | 33.8 | 15.3 | 47.4 | 100 | ||
| Slovenia | 2002 | 26.6 | 45.7 | 13 | 71.4 | |||
| Slovakia | 2002 | 24.4 | 60.1 | 7.2 | 66.1 | |||
| Finland | 2002 | 25.8 | 53.8 | 13.5 | 56.5 | |||
| Sweden | (15) | 2002 | 39 | 39 | 31 | na | ||
| United Kingdom | (16) | 2002 | 28.5 | 37 | 18 | na | ||
| Notes: | ||||||||
| Data were not available for: Estonia, Cyprus, Malta, Poland and Norway. | ||||||||
| Belgium | (1) | Data refer only to outpatient treatment centres. Last data available refer to 1999. | ||||||
| Czech Republic | (2) | Data refer to all treatment centres. | ||||||
| Germany | (4) | Data only refer to outpatient treatment centres; information about injecting use is not available. Amphetamines also include ecstasy. | ||||||
| France | (5) | The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999. | ||||||
| Ireland | (6) | Last data available refer to 2000. | ||||||
| Italy | (7) | Data only refer to outpatient treatment centres. | ||||||
| Latvia | (8) | Data refer only to outpatient treatment centres. | ||||||
| Netherlands | (12) | Data refer only to outpatient treatment centres. | ||||||
| Austria | (13) | Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. | ||||||
| Sweden | (15) | Data refer only to outpatient treatment centres | ||||||
| United Kingdom | (16) | Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001. | ||||||
| Spain | (17) | Data on men and women only concern outpatient treatment centres. | ||||||
| Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources. | ||||||||
